The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is regarded as a pandemic that affects about a quarter of the global population. Recently, host-gut microbiota metabolic interactions have emerged as distinct mechanistic pathways implicated in the development of NAFLD. Here, we report that a group of gut microbiota-modified bile acids (BAs), hyodeoxycholic acid (HDCA) species, are negatively correlated with the presence and severity of NAFLD. HDCA treatment has been shown to alleviate NAFLD in multiple mouse models by inhibiting intestinal farnesoid X receptor (FXR) and upregulating hepatic CYP7B1. Additionally, HDCA significantly increased abundances of probiotic species such as Parabacteroides distasonis, which enhances lipid catabolism through fatty acid-hepatic peroxisome proliferator-activated receptor alpha (PPARα) signaling, which in turn upregulates hepatic FXR. These findings suggest that HDCA has therapeutic potential for treating NAFLD, with a unique mechanism of simultaneously activating hepatic CYP7B1 and PPARα.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Self-citationFibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Lee, J.-H., Kim, D., Kim, H. J., Lee, C.-H., Yang, J. I., Kim, W., Kim, Y. J., Yoon, J.-H., Cho, S.-H., Sung, M.-W., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.08.002 · Cited by 1,621
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303816 · Cited by 1,001
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Huang, F., Zheng, X., Ma, X., Jiang, R., Zhou, W., Zhou, S., Zhang, Y., Lei, S., Wang, S., Kuang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12896-x · Cited by 789
Self-citationIntestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Self-citationA Global View of the Interplay between Non-Alcoholic Fatty Liver Disease and Diabetes
Stefan, N., & Cusi, K. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00003-1 · Cited by 593
Verdam, F. J., Fuentes, S., de Jonge, C., Zoetendal, E. G., Erbil, R., Greve, J. W., Buurman, W. A., de Vos, W. M., & Rensen, S. S. (2013) · Obesity · doi:10.1002/oby.20466 · Cited by 587
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Khan, R. S., Bril, F., Cusi, K., & Newsome, P. N. (2019) · Hepatology · doi:10.1002/hep.30429 · Cited by 542
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00566-7 · Cited by 490
Zheng, X., Chen, T., Jiang, R., Zhao, A., Wu, Q., Kuang, J., Sun, D., Ren, Z., Li, M., Zhao, M., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.017 · Cited by 458
Self-citationThe role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Sun, L., Cai, J., & Gonzalez, F. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00404-2 · Cited by 435
Kars, M., Yang, L., Gregor, M. F., Mohammed, B. S., Pietka, T. A., Finck, B. N., Patterson, B. W., Horton, J. D., Mittendorfer, B., Hotamisligil, G. S., et al. (2010) · Diabetes · doi:10.2337/db10-0308 · Cited by 400
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Ratziu, V., de Ledinghen, V., Oberti, F., Mathurin, P., Wartelle-Bladou, C., Renou, C., Sogni, P., Maynard, M., Larrey, D., Serfaty, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.030 · Cited by 338
Targeting the alternative bile acid synthetic pathway for metabolic diseases
Jia, W., Wei, M., Rajani, C., & Zheng, X. (2021) · Protein & Cell · doi:10.1007/s13238-020-00804-9 · Cited by 325
Self-citationLeuschner, U. F. H., Lindenthal, B., Herrmann, G., Arnold, J. C., Rössle, M., Cordes, H., Zeuzem, S., Hein, J., & Berg, T. (2010) · Hepatology · doi:10.1002/hep.23727 · Cited by 317
Metabolic Messengers: ceramides
Summers, S. A., Chaurasia, B., & Holland, W. L. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0134-8 · Cited by 299
A Metabolite Array Technology for Precision Medicine
Xie, G., Wang, L., Chen, T., Zhou, K., Zhang, Z., Li, J., Sun, B., Guo, Y., Wang, X., Wang, Y., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04686 · Cited by 266
Self-citationPreclinical Models for Studying NASH-Driven HCC: How Useful Are They?
Febbraio, M. A., Reibe, S., Shalapour, S., Ooi, G. J., Watt, M. J., & Karin, M. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.012 · Cited by 253
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
Wei, M., Huang, F., Zhao, L., Zhang, Y., Yang, W., Wang, S., Li, M., Han, X., Ge, K., Qu, C., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102766 · Cited by 253
Self-citationDysregulated hepatic bile acids collaboratively promote liver carcinogenesis
Xie, G., Wang, X., Huang, F., Zhao, A., Chen, W., Yan, J., Zhang, Y., Lei, S., Ge, K., Zheng, X., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30219 · Cited by 252
Self-citationLiu, J., Ayada, I., Zhang, X., Wang, L., Li, Y., Wen, T., Ma, Z., Bruno, M. J., de Knegt, R. J., Cao, W., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.02.030 · Cited by 242
Self-citationAnimal models for liver disease – A practical approach for translational research
Nevzorova, Y. A., Boyer-Diaz, Z., Cubero, F. J., & Gracia-Sancho, J. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.011 · Cited by 241
Global multi-stakeholder endorsement of the MAFLD definition
Méndez-Sánchez, N., Bugianesi, E., Gish, R. G., Lammert, F., Tilg, H., Nguyen, M. H., Sarin, S. K., Fabrellas, N., Zelber-Sagi, S., Fan, J.-G., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00062-0 · Cited by 229
Self-citationSun, L., Pang, Y., Wang, X., Wu, Q., Liu, H., Liu, B., Liu, G., Ye, M., Kong, W., & Jiang, C. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.004 · Cited by 204
Li, M., Wang, S., Li, Y., Zhao, M., Kuang, J., Liang, D., Wang, J., Wei, M., Rajani, C., Ma, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29589-7 · Cited by 175
Self-citationImpaired Generation of 12-Hydroxylated Bile Acids Links Hepatic Insulin Signaling with Dyslipidemia
Haeusler, R. A., Pratt–Hyatt, M., Welch, C. L., Klaassen, C. D., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.010 · Cited by 163
Hyocholic acid species as novel biomarkers for metabolic disorders
Zheng, X., Chen, T., Zhao, A., Ning, Z., Kuang, J., Wang, S., You, Y., Bao, Y., Ma, X., Yu, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21744-w · Cited by 163
Self-citationConjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis
Xie, G., Jiang, R., Wang, X., Liu, P., Zhao, A., Wu, Y., Huang, F., Liu, Z., Rajani, C., Zheng, X., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103290 · Cited by 129
Self-citationObeticholic acid-a new therapy in PBC and NASH
Chapman, R. W., & Lynch, K. D. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa006 · Cited by 116
Obeticholic Acid: First Global Approval
Markham, A., & Keam, S. J. (2016) · Drugs · doi:10.1007/s40265-016-0616-x · Cited by 116
Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver
Guillén, N., Navarro, M. Á., Arnal, C., Noone, E., Arbonés-Mainar, J. M., Acı́n, S., Surra, J. C., Muniesa, P., Roche, H. M., & Osada, J. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90339.2008 · Cited by 113
Bile Acid–Microbiome Interaction Promotes Gastric Carcinogenesis
Wang, S., Kuang, J., Zhang, H., Chen, W., Zheng, X., Wang, J., Huang, F., Ge, K., Li, M., Zhao, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202200263 · Cited by 101
Self-citationKuang, J., Zheng, X., Huang, F., Wang, S., Li, M., Zhao, M., Sang, C., Ge, K., Li, Y., Li, J., et al. (2020) · Metabolites · doi:10.3390/metabo10110475 · Cited by 69
Self-citationHepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport
Xie, C., Takahashi, S., Brocker, C. N., He, S., Chen, L., Xie, G., Jang, K., Gao, X., Krausz, K. W., Qu, A., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.05.014 · Cited by 68
Self-citationKakiyama, G., Marques, D., Martin, R., Takei, H., Rodríguez‐Agudo, D., LaSalle, S. A., Hashiguchi, T., Liu, X., Green, R. R., Erickson, S. K., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000924 · Cited by 64
Self-citationIncreased levels of conjugated bile acids are associated with human bile reflux gastritis
Zhao, A., Wang, S., Chen, W., Zheng, X., Huang, F., Han, X., Ge, K., Rajani, C., Huang, Y., Yu, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68393-5 · Cited by 33
Self-citationLiu, Y., Song, A., Yang, X., Zhen, Y., Chen, W., Yang, L., Wang, C., & Ma, H. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3715 · Cited by 31
Self-citationJiang, J., Ma, Y., Liu, Y., Lu, D., Gao, X., Krausz, K. W., Desai, D. H., Amin, S., Patterson, A. D., Gonzalez, F. J., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2099 · Cited by 29
Self-citationEvangelakos, I., Schwinge, D., Worthmann, A., John, C., Roeder, N., Pertzborn, P., Behrens, J., Schramm, C., Scheja, L., & Heeren, J. (2021) · Cells · doi:10.3390/cells10102656 · Cited by 25
Cited by
Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
What defines a healthy gut microbiome?
Van Hul, M., Cani, P. D., Petitfils, C., De Vos, W. M., Tilg, H., & El-Omar, E. M. (2024) · Gut · doi:10.1136/gutjnl-2024-333378 · Cited by 369
Next-generation probiotics: Innovations in safety assessments
Hua, Z., Liu, S., Yang, G., Hou, X., & Fang, Y. (2025) · Current Opinion in Food Science · doi:10.1016/j.cofs.2024.101238 · Cited by 29
The role of the microbiome in liver disease
Schöler, D., & Schnabl, B. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001013 · Cited by 16
Deficiency of Epithelial PIEZO1 Alleviates Liver Steatosis Induced by High-Fat Diet in Mice
Xu, Z., Xu, S., Liu, X., Cheng, L., Liu, X., Xie, X., Zhou, D., Wang, D., Chen, J., Deng, X., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.102906 · Cited by 5
Self-citation
Metadata
- Authors
- Kuang, J., Wang, J., Li, Y., Li, M., Zhao, M., Ge, K., Zheng, D., Cheung, K. C. P., Liao, B., Wang, S., Chen, T., Zhang, Y., Wang, C., Ji, G., Chen, P., Zhou, H., Xie, C., Zhao, A., Jia, W., Zheng, X., & Jia, W.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 35
- Issue
- 10
- Pages
- 1752-1766.e8
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W4385968768
- Cited by
- 321
- References
- 50
- FWCI
- 53.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.